This study examines the response to dexamethasone-doxorubicin-vincristine (DAV) therapy, followed by conditioning regimen and autologous stem cells transplantation (ASCT) in patients with multiple myeloma in relation with the presence of polymorphisms in genes involved in drug metabolism (GSTP1) and DNA synthesis (TYMS). GSTP1 G313G genotype (OR = 5.49; 95% Cl, 1.3-22.5, p = 0.02) and TYMS A227A genotype (OR = 3.4 1; 95% Cl, 1.3-8.9, p = 0.01) resulted significantly associated with a poor response following chemotherapy and the risk increased for the combined genotype (OR= 13.54; 95% Cl, 2.0-91.3, p=0.01). TYMS T157T genotype was significantly associated with a poor response after ASCT (OR=4.60; 95% Cl, 1.2-16.9, p = 0.02). Pre-therapeutic individual determination of the GSTP1 and TYMS polymorphisms could help in choosing the most appropriate protocol.

Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms

BUDA, GABRIELE;GALIMBERTI, SARA;BARALE, ROBERTO;PETRINI, MARIO;ROSSI, ANNA MARIA
2008-01-01

Abstract

This study examines the response to dexamethasone-doxorubicin-vincristine (DAV) therapy, followed by conditioning regimen and autologous stem cells transplantation (ASCT) in patients with multiple myeloma in relation with the presence of polymorphisms in genes involved in drug metabolism (GSTP1) and DNA synthesis (TYMS). GSTP1 G313G genotype (OR = 5.49; 95% Cl, 1.3-22.5, p = 0.02) and TYMS A227A genotype (OR = 3.4 1; 95% Cl, 1.3-8.9, p = 0.01) resulted significantly associated with a poor response following chemotherapy and the risk increased for the combined genotype (OR= 13.54; 95% Cl, 2.0-91.3, p=0.01). TYMS T157T genotype was significantly associated with a poor response after ASCT (OR=4.60; 95% Cl, 1.2-16.9, p = 0.02). Pre-therapeutic individual determination of the GSTP1 and TYMS polymorphisms could help in choosing the most appropriate protocol.
2008
Maggini, V; Buda, Gabriele; Galimberti, Sara; Conidi, E; Giuliani, N; Morabito, F; Genestreti, G; Iacopino, P; Rizzoli, V; Barale, Roberto; Petrini, Mario; Rossi, ANNA MARIA
File in questo prodotto:
File Dimensione Formato  
Response to chemotherapy.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 168.07 kB
Formato Adobe PDF
168.07 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/110748
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact